Medtech company with ties to CWRU, UH completes $70 million IPO
Crain’s Cleveland Business: Sanford Markowitz, the Ingalls Professor of Cancer Genetics and Medicine at the School of Medicine, discussed the $70 million initial public offering of Lucid Diagnostics, a company that makes esophageal cancer tests, developed by faculty at the School of Medicine and University Hospitals.